Research peptides, by price
Every compound we track, grouped by research cluster. Sorted by data coverage. All prices research use only.
Each tile shows two prices: cheapest $/mg, and best value by trust (the cheapest from a vendor that publishes a third-party COA). Comparisons default to $/mg; compound pages also offer price and Vendor Score sorting.
Compound collection
Metabolic / GLP-1
Triple-agonist GLP-1 candidate; the highest-value buyer-intent term in the metabolic cluster.
Dual GIP/GLP-1 agonist; huge search volume, widest price dispersion we track.
The original blockbuster GLP-1; benchmark compound for the metabolic cluster.
Long-acting amylin analog, often paired with semaglutide in research.
HGH-fragment (176-191 derivative) metabolic peptide; broadly carried.
A C-terminal fragment of growth hormone studied in research on lipolytic-pathway models.
A small-molecule NNMT inhibitor studied in research on adipose-metabolism pathways.
A GLP-1/glucagon dual-agonist candidate studied in metabolic research.
A GLP-1/glucagon dual-agonist candidate studied in metabolic research.
A synthetic 33-amino-acid analog of glucagon-like peptide-2 (GLP-2); the alanine at position 2 is replaced by glycine, which makes the molecule a poorer substrate for DPP-4 than native GLP-2.
An oral small-molecule GLP-1 receptor agonist candidate studied in metabolic research.
A monoamine-reuptake-inhibitor small molecule studied in research on appetite and metabolic pathways.
A small-molecule ERR agonist studied in preclinical research on exercise-mimetic and metabolic pathways.
A small-molecule mitochondrial uncoupler studied in preclinical metabolic research.
A small-molecule AMPK activator studied in research on exercise-mimetic and metabolic pathways.
A pro-apoptotic peptide studied in preclinical research on adipose-vasculature models.
An amino-acid derivative studied in research on fatty-acid transport and energy-metabolism pathways.
Compound collection
Repair
The most-searched repair peptide — and, by reputation, the most counterfeited.
Thymosin Beta-4 fragment; the classic BPC-157 stack partner.
A short α-MSH-derived tripeptide studied in research contexts for gut and inflammatory-response models; a common add-on in repair stacks.
An erythropoietin-derived peptide (Cibinetide) investigated in preclinical work on tissue-protective and neuropathic-pain models.
An arginate salt of a BPC-derived peptide (PDA) marketed as a repair compound; studied only in early research contexts.
Compound collection
Longevity / GH
GHRH analog; flagged as a low-competition, high-ROI term for new sites.
Selective GH secretagogue; common CJC-1295 pairing and another thin-SERP opportunity.
Cellular coenzyme carried by nearly every vendor we track — our widest-coverage non-GLP compound.
GHRH-analog secretagogue with broad vendor coverage; stacks with the CJC/ipamorelin family.
GHRH-analog secretagogue; a staple of the GH-support category.
Mitochondrial-derived peptide; a fast-rising metabolic/longevity search term.
Telomere/longevity research peptide with broad vendor coverage.
A mitochondria-targeting peptide (Elamipretide / MTP-131) studied in research on cardiolipin and cellular-energy pathways.
A mitochondrial-derived peptide investigated in research on cytoprotective and metabolic-signaling models.
A senolytic peptide studied in preclinical research on senescent-cell clearance models.
A growth-hormone-releasing peptide studied in research on the GH/secretagogue axis; distinct from GHRP-6.
A growth-hormone-releasing peptide studied in research on the GH/secretagogue axis; distinct from GHRP-2.
A growth-hormone-releasing peptide studied in research on the GH/secretagogue axis.
An orally active growth-hormone secretagogue (Ibutamoren) studied in research on the GH/IGF-1 axis.
A growth-hormone secretagogue compound (Acetamoren) studied only in early research contexts.
Compound collection
Cosmetic / Copper
Copper tripeptide; a fast-rising, lower-competition keyword with strong buyer intent.
Tanning/melanocortin peptide (MT-2); one of the most-searched non-GLP peptides.
Antioxidant tripeptide; frequently sold alongside NAD+ and cosmetic peptides.
A melanocortin peptide (afamelanotide-related) studied in research on pigmentation pathways; distinct from Melanotan II.
A cosmetic acetyl-octapeptide studied in topical research on expression-line pathways.
A cosmetic acetyl-hexapeptide studied in topical research on expression-line pathways.
A copper tripeptide studied in cosmetic research on hair-follicle and skin pathways.
A synthetic tripeptide studied in cosmetic research on expression-line (muscle-contraction) pathways.
A palmitoyl-peptide (tripeptide-38 / pentapeptide-4) studied in cosmetic research on collagen-support pathways.
Compound collection
Bioregulators
A short peptide bioregulator studied in early research contexts around neural/pineal tissue.
A short peptide bioregulator studied in early research contexts around cartilage/connective tissue.
A short peptide bioregulator studied in early research contexts around cardiac tissue.
A short peptide bioregulator studied in early research contexts around reproductive tissue.
A short peptide bioregulator studied in early research contexts around immune/thymic tissue.
A short peptide bioregulator studied in early research contexts around hepatic/gastrointestinal tissue.
A short peptide bioregulator studied in early research contexts around vascular tissue.
A short peptide bioregulator studied in early research contexts around prostate tissue.
A short peptide bioregulator studied in early research contexts around hepatic/gastrointestinal tissue.
A short peptide bioregulator studied in early research contexts around neural/cortical tissue.
A short peptide bioregulator studied in early research contexts around immune/thymic tissue.
A short peptide bioregulator studied in early research contexts around respiratory tissue.
A short peptide bioregulator studied in early research contexts around respiratory tissue.
A short peptide bioregulator studied in early research contexts around pancreatic tissue.
Compound collection
Nootropic
Anxiolytic nootropic peptide; commonly paired with Semax.
Widely-sold nootropic peptide; frequently stacked with Selank.
An angiotensin-derived peptide studied in preclinical research on synaptic-plasticity models.
An adamantane-linked nootropic peptide studied only in early research contexts.
A neuropeptide preparation studied in research on neurotrophic-support pathways.
A neurotrophic peptide (P021) studied in preclinical research on cognition and BDNF-pathway models.
Compound collection
Immune
Immune-modulating thymic peptide (Tα1); distinct from TB-500 (Thymosin Beta-4).
A cathelicidin-derived antimicrobial peptide (CAP-18) studied in research on host-defense and wound-healing models.
A thymic peptide preparation studied in research contexts for immune-regulation pathways.
A zinc-dependent thymic peptide investigated in research on immune-signaling models.
Compound collection
Other research peptides
Bremelanotide; a high-demand melanocortin peptide carried by most vendors.
Delta sleep-inducing peptide; a recognizable, widely-listed research term.
Reproductive-axis signaling peptide; a distinct, growing search term.
Long-R3 insulin-like growth factor; a staple bodybuilding-research peptide.
Vasoactive Intestinal Peptide, a signaling peptide studied in research settings for gut, circadian and immune-modulation pathways.
Mechano-Growth Factor, an IGF-1 splice variant studied in research on muscle-repair signaling.
An activin/myostatin-binding protein studied in research on muscle and tissue-growth pathways.
A p53-derived peptide studied in preclinical cancer-cell research models.
A gonadotropin-releasing hormone (GnRH) peptide studied in research on the reproductive axis.
A parathyroid-hormone fragment studied in research on bone-metabolism pathways.
Human chorionic gonadotropin, a glycoprotein hormone studied in research on the reproductive/endocrine axis.
A nine-amino-acid neuropeptide studied in research on social-bonding and signaling pathways.
A small-molecule redox compound studied in research on mitochondrial electron-transport pathways.
A seven-amino-acid spadin analogue studied preclinically as a TREK-1 channel inhibitor.
An investigational ActRIIB-Fc fusion protein studied as an inhibitor of myostatin and related ligands.
An NCAM-derived peptide studied preclinically in neuronal plasticity and inflammatory-signaling models.
A truncated IGF-I analogue with reduced binding to IGF-binding proteins, studied mainly in preclinical models.
Named multi-compound products
Blends
Compared by total product price because different compounds are not interchangeable milligram-for-milligram.